Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more
Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue
